Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,CαMeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 56-64

  De Fonseca, Fernando Rodrígue ^a   Rubio, Pilar ^a   Menzaghi, Frédérique ^b,d   Merlo Pich, Emilio ^b,e   Rivier, Jean ^c   Koob, George F ^b   Navarro, Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d SIBIA Corp   (United States)

^e GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXANABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL REFLEX;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DEFENSE MECHANISMS; DRUG INTERACTIONS; DRUG SYNERGISM; MALE; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRESS; SWIMMING; TETRAHYDROCANNABINOL;

EID: 0029996453     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. ABOOD, M. E. AND MARTIN, B E.: Neurobiology of marijuana abuse. Trends Pharmacol. Sci. 13: 201-205, 1992.
2. ANDREASSON, S., ALLEBECK, P., ENGSTRÖM, A. AND RYDBERG, V.: Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet ii: 1483-1486, 1987.
3. BALDWIN, H A., RASSNICK, S., KOOB, G. F. AND BRITTON, K. T.: CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103: 227-232, 1991.
4. BERRIDGE, C. W. AND DUNN, A. J.: Restraint stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. J. Neurosci. 9: 3513-3521, 1989.
5. BLANCHARD, R. J., KELLEY, M. J. AND BLANCHARD, D. C.: Defensive reactions and exploratory behavior in rats. J. Comp. Physiol. Psychol 87: 1129-1133, 1974.
6. BRITTON, D. R., KOOB, G. F., RIVIER, J. AND VALE, W.: Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31: 363-367, 1982
7. BRITTON, K. T., LEE, G., VALE, W., RIVIER, J. AND KOOB, G. F.: Corticotropin releasing factor (CRF) receptor antagonist blocks activating and "anxiogenic" actions of CRF in the rat Brain Res. 369: 303-306, 1986.
8. CHEN, J., PAREDES, W., LI, J., SMITH, D., LOWINSON, J. AND GARDNER, E. L.: Delta-9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102: 156-162, 1990.
9. DEVANE, W. A., DYSARZ, F. A. III, JOHNSON, M. R., MELVIN, L. S AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
10. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, R G., GRIFFIN, G , GIBSON, D., MANDELBAUM, L A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash. DC) 258: 1946-1949, 1992
11. DEWEY, W. L.. Cannabinoid pharmacology. Pharmacol. Rev. 38: 151-178, 1986.
12. DUNN, A. J. AND FILE, S. E.: Corticotropin-releasing factor has an anxiogenic action on the social interaction test Horm. Behav. 21: 193-202, 1987.
13. EMILIO M.-P., MARGE L., MARK Y., FERNANDO R. DE F., JACOB R., GEORGE F. K. AND FRIEDBEST W.: Increase of extracellular corticotropin-releasing factor-like, immunoreactivity levels in the amygdala of a wave rats during restraint stress and ethanol withdrawal as measured by microdialysis. Neuroscience, 15: 5439-5447, 1995
14. FISHMAN, M W., ROSENBAUM, J. F., YABUSAKI, D. I. AND CARR, D. B.: Marijuana related anxiety: A questionnaire based pilot study of normal and psychiatric populations. Res. Commun. Subst. Abuse 9: 219-226, 1988.
15. FRIDE, E. AND MECHOULAM, R.: Pharmacological activity of the cannabinoid receptor agonist anandamide, a brain constituent. Eur. J. Pharmacol. 231: 447-454, 1993.
16. GAONI, Y. AND MECHOULAM, R.: Isolation, structure and partial synthesis on an active constituent of hashish. J. Am. Chem. Soc. 86: 1646-1654, 1964.
17. GUIMARAES, F. S., DE AGUIAR, J. C., MECHOULAM, R. AND BREUER, A.: Anxyolitic effect of cannabidiol derivatives in the elevated plus-maze. Gen. Pharmacol. 25: 161-164, 1994.
18. GARDNER, E. L.: Cannabinoid interaction with brain reward systems - The neurobiological basis of cannabinoid abuse. In Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse, Vol. IV, ed. by A. Bartke and L. L. Murphy, pp 275-336, CRC Press, Boca Raton, 1992.
19. HALIKAS, J. A., WELLER, R. A., MOUSE, C. L. AND HOFFMAN, R. A.: A longitudinal study of marijuana effects. Int. J. Addict. 20: 701-711, 1985
20. HEINRICHS, S. C., MERLO-PICH, E., MICZECK, K. A , BRITTON, K. T. AND KOOB, G. F.: Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581: 190-197, 1992.
21. 9-tetrahydrocannabinol and the synthetic cannabinoid CP-55,940 induce expression of c-fos mRNA in stress-responsive nuclei of rat brain. Soc Neurosci Abstr. 20: 1676, 1994.
22. HERKENHAM, M., LYNN, A. B., DE COSTA, B. R. AND RICHFIELD, E. K.: Neuronal localization of cannabinoid receptors in the basal ganglia of the rat Brain Res. 547: 267-274, 1991a.
23. HERKENHAM, M., LYNN, A. B., JOHNSON, M. R., MELVIN, L. S., DE COSTA, B. R. AND RICE, K. C.: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11: 563-583, 1991b
24. HOLLISTER, L. E.: Health aspects of cannabis. Pharmacol, Rev. 38: 1-20, 1986
25. HOWLETT, A. C., CHAMPION-DOROW, T. M., MCMAHON, I. L. AND WESTLAKE, T. M.: The cannabinoid receptor: Biochemical and cellular properties in neuroblastoma cells. Pharmacol. Biochem. Behav. 40: 565-569, 1991.
26. KOOB, G. F., HEINRICHS, S. C., MERLO-PICH, E., MENZAGHI, F., BALDWIN, H., MICZEK, H. AND BRITTON, K. T.: The role of corticotropin-releasing factor in behavioural response to stress. In Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide, ed by E. B. de Souza and C. B. Nemeroff, pp. 277-295, 1993.
27. 8-tetrahydrocannabinol-dimethylheptyl on mice and dogs Pharmacol. Biochem. Behav. 32: 661-666, 1989.
28. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature (Lond.) 346: 561-564, 1990.
29. MENZAGHI, F., HOWARD, R. L., HEINRICHS, S. C., VALE, W., RIVIER, J. AND KOOB, G. F.: Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 269: 564-572, 1994.
30. NABILOFF, B. D., RICKLESS, W. H., COHEN, M. J. AND NAIMARK, B. S.: Interactions of marijuana and induced stress: Forearm blood flow, heart rate, and skin conductance. Psychophysiology 13: 517-522, 1976.
31. 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav. Brain. Res. 57: 37-46, 1993a.
32. 9-tetrahydrocannabinol. Possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav. 45: 291-298, 1993b.
33. 9-tetrahydrocannabinol. An ontogenic study in Wistar rats. Psychopharmacology 116: 414-422, 1994.
34. ONAIVI, E. S., GREEN, M. E. AND MARTIN, B. E.: Pharmacological characterization of cannabinoids in the elevated plus-maze. J. Pharmacol. Exp. Ther. 253: 1002-1009, 1990.
35. RIVIER, J., RIVIER, C., GALYEAN, R., YAMAMOTO, G. AND VALE, W.: Corticotropin-releasing factor: Characterization of new analogs. In Peptide Chemistry 1987, ed. by T. S. Sakakibara and S. Sakakibara, pp 597-600, Protein Research Foundation, Osaka, 1988.
36. RODRÍGUEZ DE FONSECA, F. A., FERNÁNDEZ-RUIZ, J. J., ELDRIDGE, J. C., STEGER, R. W., BARTKE, A. AND MURPHY, L.: Effects of the exposure to delta-9-tetrahydrocannabinol on the adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol. Biochem. Behav. 40: 593-698, 1991.
37. 8-tetrahydrocannabinol-dimethylheptyl-induced catalepsy in male rats. NeuroReport 5: 761-765, 1994.
38. RODRÍGUEZ DE FONSECA, F., VILLANÚA, M. A., MUNOZ, R. M., SAN-MARTIN-CLARKE, O. AND NAVARRO, M.: Differential effects of chronic treatment with either dopamine D-1 or D-2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats. Neuroendocrinology 61: 714-721, 1995.
39. SANANES, C. B. AND DAVIS, M.: N-methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala, block fear-potentiated startle and shock sensitization startle. Behav. Neurosci 106: 72-80, 1992.
40. SETHI, B. B., TRIVEDI, J. K., KUMAR, P., GULATI, A., AGARWAL, A. K. AND SETHI, N : Antianxiety effects of cannabis: Involvement of central benzodiazepine receptors. Biol. Psychiatry 21: 3-10, 1986
41. SWANSON, L. W., SAWCHENKO, P. E., RIVIER, J. AND VALE, W. W.: Organization of ovine corticotropin-releasing factor inmunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186, 1983.
42. TAKAHASI, L. K., KALIN, N. H., VAN DE BURGT, J. A. AND SHERMAN, J. E.: Corticotropin-releasing factor modulates defensive withdrawal and exploratory behavior in rats. Behavi. Neurosci. 103: 648-654, 1989.
43. WEIDENFELD, J., FELDMAN, S. AND MECHOULAM, R.: Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamus-pituitary-adrenal axis in the rat. Neuroendocrinology 59: 110-112, 1993.
44. WESTLAKE, T M., HOWLETT, A. C., BONNER, T. I., MATSUDA, L. A. AND HERKENHAM, M.: Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63: 637-652, 1994.
45. YANG, X. M., GORMAN, A. L. AND DUNN, A. J.: The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther. 255: 1064-1070, 1990.
46. 9-tetrahydrocannabinol in normal subjects Psychopharmacology 76: 245-250, 1982.